NA
AHCO icon

Navellier & Associates’s AdaptHealth AHCO Stock Holding History

Navellier & Associates’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,442
Closed -$317K – 281
2020
Q4 		$317K Buy
+8,442
New +$261K 0.06% 218

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Navellier & Associates's AHCO Position: Q1 2021 in Review

Navellier & Associates sold out of AdaptHealth (AHCO) in Q1 2021, closing a stake of 8,442 shares — an estimated $317K sold.

Navellier & Associates first reported a position in AHCO in Q4 2020 and held it in 1 quarter. The position peaked at $317K in Q4 2020. 145 funds tracked by Wall St. Rank hold AHCO as of Q1 2021.

  • Navellier & Associates reported no remaining AdaptHealth position as of Q1 2021 after selling out during the quarter.
  • Navellier & Associates sold 8,442 AdaptHealth shares in Q1 2021, an estimated $317K.
  • Navellier & Associates first reported a position in AdaptHealth in Q4 2020 and held it in 1 quarter.
  • Navellier & Associates's AdaptHealth position peaked at $317K in Q4 2020.
  • 145 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2021.

Based on Navellier & Associates's 13F filing for Q1 2021, filed 12 May 2021.